share_log

一图读懂有研粉材2021年中报

A picture to read and understand the research powder 2021 China News

證券之星 ·  Sep 21, 2021 09:27

According to the report of Securities Star data Center, Youyan Powder 2021 showed that the company's main income was 1.267 billion yuan, up 71.96% from the same period last year; the net profit from its parent was 33.7342 million yuan, up 21.27% from the same period last year; deducting 28.917 million yuan from non-net profit, up 75.94% from the same period last year; debt ratio 19.08%, investment income 273400 yuan, financial expenses-122300 yuan, gross profit 9.13%.

There are 8 new shareholders in this period. Shanghai Pudong Development Bank Co., Ltd.-Yongwin Consumer theme flexible allocation mixed Securities Investment Fund holds 562363 shares, accounting for 2.06% of tradable shares. China China Construction Bank Corporation Co., Ltd.-Bosch returns flexible allocation of mixed securities investment funds holding 171777 shares, accounting for 0.63% of tradable shares, and Hu Chenyi holds 182000 shares. Accounting for 0.67% of tradable shares, Wang Yuesheng holds 309000 shares, accounting for 1.13% of tradable shares, Ding Jianjun holds 309889 shares, accounting for 1.14% of tradable shares, Li Xueyi holds 283331 shares, accounting for 1.04% of tradable shares. Guangfa Fund-Guoxin Investment Co., Ltd.-Guofa Fund-Guoxin No. 2 single asset management plan holds 396126 shares, accounting for 1.45% of tradable shares Zhang Hongyong holds 141791 shares, accounting for 0.52% of the outstanding shares. A total of 2 shareholders increased their holdings, Huang Quancheng increased their holdings by 101046 shares, accounting for 1.46% of tradable shares, and Huang Hao increased their holdings by 94000 shares, accounting for 0.88% of tradable shares.

For a summary of the financial report data, please see the following figure:


Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment